INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

82,076 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
PY
Park Angie YChief Financial Officer
ACNAccenture plc
Tax withholding
F$1,569
7 sh
Feb 13, 2026Feb 17, 2026
Page 1559 of 2052
← PrevNext →
traded Feb 13, 2026
+4d
SEC Form 4

Evidence

9
CW
Cummings John WChief Administrative Officer
TCBITEXAS CAPITAL BANCSHARES INC/TX
Option exercise
M—
1,470 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
MM
Moore Susan MSVP, Chief Risk Officer
MOFGMidWestOne Financial Group, Inc.
Disposition to issuer
D—
15.4K sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BD
Baroni DarioPresident, IDL
MCDMCDONALDS CORP
Option exercise
M—
38 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
RS
Reeder Raymond SeanCorporate Controller & CAO
ROGROGERS CORP
Tax withholding
F$5,713
53 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BJ
Banner JonathanEVP - Chief Impact Officer
MCDMCDONALDS CORP
Option exercise
M—
2,975 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
KY
Kim YongsooSee Remarks
WBTNWEBTOON Entertainment Inc.
Tax withholding
F$50K
4,679 sh
Feb 15, 2026Feb 17, 2026
traded Feb 15, 2026
+2dSEC Form 4

Evidence

9
EA
Egawa AtsushiCo-CEO Asia Pacific
ACNAccenture plc
Grant or award
A—
21 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
SB
Shah Mitesh BansilalSVP and CHRO
VMCVulcan Materials CO
Option exercise
M—
1,684 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
SA
Smith Beth AnnVP, Controller & Treasurer
MGNXMACROGENICS INC
Option exercise
M—
1,095 sh
Feb 15, 2026Feb 17, 2026
traded Feb 15, 2026
+2dSEC Form 4

Evidence

9
BJ
Banner JonathanEVP - Chief Impact Officer
MCDMCDONALDS CORP
Option exercise
M—
215 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BL
Boyd Tiffanie L.EVP - Chief People Officer
MCDMCDONALDS CORP
Option exercise
M—
89 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
31.2K sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
MG
McDonald GillianEVP, Global Rest. Exp. Ofc.
MCDMCDONALDS CORP
Option exercise
M—
296 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
MM
Moore Susan MSVP, Chief Risk Officer
MOFGMidWestOne Financial Group, Inc.
Disposition to issuer
D—
1,353 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
MG
McDonald GillianEVP, Global Rest. Exp. Ofc.
MCDMCDONALDS CORP
Option exercise
M—
296 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
DI
Delaet IngridChief Regulatory Officer
NBIXNEUROCRINE BIOSCIENCES INC
Grant or award
A—
5,479 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BD
Baroni DarioPresident, IDL
MCDMCDONALDS CORP
Option exercise
M—
409 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
OD
O'Leary-Gill DanielaDirector
MTGMGIC INVESTMENT CORP
Grant or award
A—
1 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
MR
McPherson Danny REVP - Technology & CSO
VRSNVERISIGN INC/CA
Tax withholding
F$35K
159 sh
Feb 15, 2026Feb 17, 2026
traded Feb 15, 2026
+2dSEC Form 4

Evidence

9
BM
Brudermueller MartinDirector
ACNAccenture plc
Grant or award
A—
6 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
MG
McDonald GillianEVP, Global Rest. Exp. Ofc.
MCDMCDONALDS CORP
Option exercise
M—
4,090 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
PY
Park Angie YChief Financial Officer
ACNAccenture plc
Grant or award
A—
32 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BL
Boyd Tiffanie L.EVP - Chief People Officer
MCDMCDONALDS CORP
Option exercise
M—
70 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BJ
Banner JonathanEVP - Chief Impact Officer
MCDMCDONALDS CORP
Option exercise
M—
290 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
UM
Uotani MasahikoDirector
ACNAccenture plc
Grant or award
A—
5 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
MG
McDonald GillianEVP, Global Rest. Exp. Ofc.
MCDMCDONALDS CORP
Option exercise
M—
161 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BM
Berry Jason MEVP Chief Operating Officer
ALKALASKA AIR GROUP, INC.
Option exercise
M—
2,400 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
NJ
Nason JenniferDirector
ACNAccenture plc
Tax withholding
F$448
2 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BD
Baroni DarioPresident, IDL
MCDMCDONALDS CORP
Option exercise
M—
38 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BJ
Banner JonathanEVP - Chief Impact Officer
MCDMCDONALDS CORP
Option exercise
M—
4,015 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BD
Baroni DarioPresident, IDL
MCDMCDONALDS CORP
Option exercise
M—
30 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
BL
Boyd Tiffanie L.EVP - Chief People Officer
MCDMCDONALDS CORP
Option exercise
M—
70 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

9
LM
Lemasney MarkEVP Power Generation Division
NEENEXTERA ENERGY INC
Tax withholding
F$19K
206 sh
Feb 15, 2026Feb 17, 2026
traded Feb 15, 2026
+2dSEC Form 4

Evidence

9
SB
Shah Mitesh BansilalSVP and CHRO
VMCVulcan Materials CO
Option exercise
M—
900 sh
Feb 13, 2026Feb 17, 2026
traded Feb 13, 2026
+4dSEC Form 4

Evidence

8
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Grant or award
A—
18.8K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC Form 4

Evidence

8
DK
Davis KristaSVP, CHIEF HR OFFICER
ANIPANI PHARMACEUTICALS INC
Tax withholding
F$100K
1,290 sh
Feb 14, 2026Feb 17, 2026
traded Feb 14, 2026
+3dSEC Form 4

Evidence

8
PA
Patel AnishCHIEF OPERATING OFFICER
ELVNEnliven Therapeutics, Inc.
Grant or award
A—
20.0K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC Form 4

Evidence

8
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Grant or award
A—
112.5K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC Form 4

Evidence

8
PA
Patel AnishCHIEF OPERATING OFFICER
ELVNEnliven Therapeutics, Inc.
Grant or award
A—
120.0K sh
Feb 12, 2026Feb 17, 2026
traded Feb 12, 2026
+5dSEC Form 4

Evidence